Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...
AUSTIN, Texas--(BUSINESS WIRE)--$IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) is pleased to announce a strategic partnership with a leading ...
Patients with SLE should be assessed for their antiphospholipid antibody status, infectious and cardiovascular diseases risk profile and preventative strategies be tailored accordingly. The updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback